Ignite Creation Date:
2024-05-06 @ 7:41 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06095375
Status:
RECRUITING
Last Update Posted:
2024-02-12
First Post:
2023-03-10
Brief Title:
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated IDH Wild-type GBM Patients
Sponsor:
Istituto Oncologico Veneto IRCCS
Organization:
Istituto Oncologico Veneto IRCCS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-10
First Submit QC Date:
October 18 2023
Study First Post Date:
2023-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-09
Last Update Post Date:
2024-02-12
Last Update Post Date Type:
ACTUAL